Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03501433 · ClinicalTrials.gov registry record · NA
Effects of Nicotinamide Riboside on Metabolism and Vascular Function
A NA study, sponsored by Iowa State University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03501433 is a NA study that has completed, run by Iowa State University. The registered enrollment target is 16 participants.
The verdict
NCT03501433, a NA study, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of Nicotinamide Riboside (NR) supplementation on metabolism and vascular function following high-fat meal. Differences between young (18-35) and older (60-75) adults will be determined.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Nicotinamide riboside chloride (Niagen)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03501433
The ClinicalTrials.gov registry entry for NCT03501433 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iowa State University, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03501433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03501433 about?
NCT03501433 is a clinical study titled "Effects of Nicotinamide Riboside on Metabolism and Vascular Function". The purpose of this study is to determine the effects of Nicotinamide Riboside (NR) supplementation on metabolism and vascular function following high-fat meal. Differences between young (18-35) and older (60-75) adults will be determined.
What is the current status of trial NCT03501433?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-02-01. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03501433?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Nicotinamide riboside chloride (Niagen) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03501433?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.